Published: 30 June 2020
Author(s): Stefano Gitto, Nicola De Maria, Luca Marzi, Paolo Magistri, Margherita Falcini, Giovanni Vitale, Tiziana Olivieri, Gian Piero Guerrini, Valentina Serra, Paolo Forte, Paola Carrai, Paolo De Simone, Andrea Mega, Heinz Zoller, Guido Piai, Filippo Schepis, Margherita Marocchi, Erica Villa, Fabio Marra, Pietro Andreone, Fabrizio Di Benedetto, other members of MEDITRA research group
Section: Original article

Liver transplantation (LT) is an effective treatment for patients with acute liver failure, end-stage liver disease, and non-resectable hepatocellular carcinoma (HCC) [1]. Early after surgery, LT recipients often gain weight and develop metabolic disorders, due to both an increase in caloric intake and unfavorable metabolic effects of immunosuppressive drugs [2-4]. Weight gain is already evident six months after transplantation in most patients [5] and one third of transplanted patients are obese after 3 years [5].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.